Factors Associated With Hospitalization for Dengue and Dengue Severity: Hospital-based Cohort Study on Reunion Island
DENGUE-RUN
1 other identifier
interventional
258
1 country
1
Brief Summary
In recent years, dengue has become endemic on La Réunion island, which has led to subsequent increase of secondary dengue infections, higher severity and higher mortality of the cases referred to the hospital. This project will investigate the factors associated with the hospitalization for dengue and the factors associated with dengue severity in a hospital-based cohort study conducted over two dengue seasons, as well as the long-term outcomes over aN18-month follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2022
CompletedStudy Start
First participant enrolled
March 30, 2022
CompletedFirst Posted
Study publicly available on registry
November 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedAugust 21, 2024
August 1, 2024
3 years
January 6, 2022
August 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The relative risk for hospitalization with dengue of any risk factors measured at inclusion )
The incidence rate ratio (relative risk) for hospitalization with dengue of any risk factors measured at inclusion (first consultation) as identified from a multivariate Poisson regression model for dichotomous outcome.
18 months
Study Arms (1)
All patient with Dengue prognostic purpose
OTHERblood samples for bio collection clinical exam : Fitzpatrick phototype classification , Charlson comorbidity classification questionaries : SHERE and EHAD (emotional evaluation), SF-12, EQ-5D-5L, MFIS-5 (Fatigue evaluation)
Interventions
clinical exam Charlson comorbidity classification questionaries : SHERE and EHAD (emotional evaluation), SF-12, EQ-5D-5L, MFIS-5 (Fatigue evaluation) during 18 months
Eligibility Criteria
You may qualify if:
- Adult patients (including pregnant women) or children (\> 8 kg)
- Admitted to the Emergency Department, in the hospital wards, or in outpatient clinics from the two teaching hospitals of Réunion island
- with a definite or probable diagnosis of dengue, as defined by a positive PCR (plasma or urine), NS1 antigen within the first five days of onset of symptoms; or 2 serologies indicating a recent primary or a secondary infection (positive IgM twice or IgG seroconversion x 4 at a minimum of 10 days apart)
- affiliated to a social insurance
You may not qualify if:
- refusal of participation as expressed by the patient or its entourage (if the patient is physically unable to give his opinion)
- absence of social insurance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Patrick GERARDIN
Saint-Pierre, 97410, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Manuella POTHIN
CHU La Réunion
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2022
First Posted
November 7, 2022
Study Start
March 30, 2022
Primary Completion
March 30, 2025
Study Completion
March 30, 2025
Last Updated
August 21, 2024
Record last verified: 2024-08